glp-1 and anxiety Beyond the scale: How medications are affecting both body mind The risk of depression, anxiety,
Description
Caufriez, A., Leproult, R., L'Hermite-Balriaux, M., Kerkhofs, M., & Copinschi, G
The enzyme dipeptidyl peptidase-4 (DPP-4) rapidly degrades circulating GLP-1, which is why pharmaceutical versions are chemically modified to resist this breakdown and maintain therapeutic levels for extended periods
Notably, most side effects decrease as the body adapts to the medication over time
Another study in a GIP receptor knockout model showed decreased bone strength and cortical thickness and increased bone resorptionbut paradoxically, an increased number of osteoblasts and a reduced number of osteoclasts [49]
When you stop a GLP-1, the medication leaves your system gradually over several weeks
If the insurance company denies your request, you still have options
